患者様やご家族など一般の方向け臨床・治癒情報サイト　臨床研究情報ポータルサイト

• 進捗状況
• 試験名
• 対象疾患名
• 地域
• 登録日
•  

• Not recruiting

• The Effect of Normal Cervical Sagittal Configuration in the Management of Cervicogenic Dizziness: A 1-Year Randomized Controlled Study
• Cervicogenic Dizziness
• ,Outside, Egypt
• 2013-11-25

• Not recruiting

• A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab
• Breast Cancer;Ovarian Cancer;Colorectal Cancer;Cervical Cancer;Renal Cell Carcinoma
• United States
• 2013-10-29

• Recruiting

• MVX-ONCO-1 in Patients With Solid Tumor
• Solid Tumor;Cancer
• Switzerland
• 2013-08-26

• Not recruiting

• A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Subjects With Type 1 Diabetes
• Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1
• Austria
• 2013-08-14

• Not Recruiting

• Perioperative intravenous insulin, GIK or GLP-1 treatment in DM
• Patients with diabetes mellitus type 2 who will undergo non-cardiac surgery MedDRA version: 19.0 Level: PT Classification code 10058829 Term: Elective surgery System Organ Class: 10042613 - Surgical and medical procedures MedDRA version: 19.0 Level: LLT Classification code 10049746 Term: Insulin-requiring type II diabetes mellitus System Organ Class: 100000004861 ;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]
• Netherlands
• 2013-08-13

• Recruiting

• Peripheral Histamine 1 Receptor Blockade in IBS: Multicenter Trial
• Irritable Bowel Syndrome (IBS);Irritable Bowel Syndrome (IBS);Irritable Bowel Syndrome (IBS);Irritable Bowel Syndrome (IBS)
• Belgium, Netherlands
• 2013-07-19

• Not recruiting

• A Phase 1 Study to Investigate the Food Effect of Lumacaftor in Combination With Ivacaftor
• Cystic Fibrosis
• United States
• 2013-07-10

• Not recruiting

• Liraglutide in Newly Onset Type 1 Diabetes.
• Diabetes Mellitus, Type 1
• Denmark
• 2013-06-14

• Not recruiting

• Phase 1 Pharmacokinetic Study of Tapentadol Prolonged-Release 250 Milligram (mg) Formulation in Healthy Participants
• Healthy
• Netherlands
• 2013-06-11

• Not recruiting

• Phase 1 Study in Subjects With OAB Assessing the Safety and Activity of hMaxi-K Gene Transfer
• OAB (Overactive Bladder Syndrome and Detrusor Overactivity);OAB (Overactive Bladder Syndrome and Detrusor Overactivity);OAB (Overactive Bladder Syndrome and Detrusor Overactivity);OAB (Overactive Bladder Syndrome and Detrusor Overactivity)
• United States
• 2013-06-03

• Not recruiting

• Schistosoma Mansoni Morbidity in Children Aged 1-5 Years
• Intestinal Schistosomiasis
• Uganda
• 2013-05-30

• Recruiting

• A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1)
• Hypertriglyceridemia;Hypertriglyceridemia
• United States
• 2017-11-21

• A Phase 1 Clinical Study of E6130 -Clinical Pharmacology Study in Healthy Adult Male Subjects-
• Healthy Adult Subjects
• 2017-11-20

• Not recruiting

• Two Narrative Medicine Interventions in Type 1 Diabetes
• Type1diabetes;Type1diabetes;Type1diabetes;Type1diabetes
• 2017-11-17

• Not Recruiting

• Dishabituation as a treatment for impaired awareness of hypoglycaemia in type 1 diabetes
• Type 1 diabetes Nutritional, Metabolic, Endocrine Type 1 diabetes mellitus
• United Kingdom
• 2017-10-25

• Not recruiting

• Phase 1 Study of Safety, Tolerability and Pharmacokinetics of SPR994
• Healthy Volunteers;Healthy Volunteers
• Australia
• 2017-10-19

• Not recruiting

• Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1
• Melanoma;Non-small Cell;Lung Cancer;Melanoma;Non-small Cell;Lung Cancer;Melanoma;Non-small Cell;Lung Cancer;Melanoma;Non-small Cell;Lung Cancer
• France
• 2017-10-10

• Recruiting

• Phase 1 Study of IM156 in Patients With Advanced Solid Tumor
• Advanced Solid Tumor
• Korea, Republic of
• 2017-08-29

• Not Recruiting

• The study of the effects of yogurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 on the immunity function in elderly persons
• weakened immune systems
• Japan
• 2017-08-10

• Authorised

• A Phase 1/2, Open-Label, Dose-Escalation/Dose-Expansion, Safety and Tolerability Study of INCB059872 in Subjects With Advanced Malignancies
• Potential subjects include those with advanced or metastatic malignancies who are ineligible for all therapeutic options that are standard of care or known to confer clinical benefit, or who refuse these treatments. MedDRA version: 20.0 Level: LLT Classification code 10048683 Term: Advanced cancer System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
• Belgium, Netherlands, United States
• 2017-08-09